Shares of Bark Inc (NYSE:BARK) rose sharply in pre-market trading after a 13D filing disclosed that Great Dane delivered a non-binding letter to the board to acquire the company.Bark shares jumped 19.9% to $0.74 in the pre-market trading session.Here are some other stocks moving in pre-market trading.GainersSigning Day Sports Inc (NYSE:SGN) gained 43.7% to $0.71 in pre-market trading.Ping An Biomedical Co Ltd (NASDAQ:PASW) rose 34.3% to $0.27 in pre-market trading after dipping 68% on Friday.Abivax SA (NASD ...

Several biotech and healthcare names posted notable gains in after-hours trading on Friday, with investors showing renewed interest in companies tied to drug development, healthcare services, and financing updates.Zentalis Pharmaceuticals, Inc. (ZNTL) led the pack, surging 17.65% to close at $4.40, up $0.66 in the after-hours session. While there was no fresh news on Friday, the company recently provided a corporate update on January 6, 2026, highlighting key milestones and expected momentum in its azenose ...

TAIZHOU, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive agreement with a single investor for the purchase and sale of an aggregate of 66,666,666 Class A ordinary shares of the company, no par value per share (the “Shares”) (or pre-funded warrants in lieu thereof), at a purchase price of $0.15 per share in a registered direct offering. The purchase price for each pre-funded warrant is identical to t ...

Core Insights - Several biotechnology and pharmaceutical companies experienced significant stock price increases in after-hours trading, driven by corporate updates, clinical milestones, and acquisition speculation [1] Company Updates - China SXT Pharmaceuticals, Inc. (SXTC) saw a 13.6% increase to $1.42, following the announcement of its Strategic Artificial Intelligence Insights Initiative aimed at integrating AI-driven analytics into product planning and market intelligence [2] - Revolution Medicines, Inc. (RVMD) surged 15.1% to $123.65 after reports of Merck's acquisition talks and the FDA granting Breakthrough Therapy Designation to its drug zoldonrasib for treating specific lung cancer patients [3] - KalVista Pharmaceuticals, Inc. (KALV) advanced 14.0% to $18.04 after reporting preliminary unaudited global net product revenue results for Q4 and the full year ended December 31, 2025, along with other operational indicators [4] - Zentalis Pharmaceuticals, Inc. (ZNTL) rose 8.1% to $3.07, likely due to investor reactions to a previous corporate update outlining key milestones for its drug azenosertib [5] - BriaCell Therapeutics Corp. (BCTX) gained 7.3% to $7.81 without new announcements, indicating momentum-driven trading [6] - Sagimet Biosciences Inc. (SGMT) increased 7.7% to $6.00 after announcing plans to present clinical trial results at an upcoming conference, highlighting anti-fibrotic effects observed in patients [7]

中概股收盘跌幅居前的个股为：铭腾国际跌43.15%，苏轩堂跌37.5%，脑再生科技跌21.67%，拍明芯城 跌17.65%，星图国际跌15.63%。(格隆汇) | 代码 | 名称 | 最新价 | 涨跌幅 ^ | 涨跌额 | 成交额 | | --- | --- | --- | --- | --- | --- | | MTEN | 铭腾国际 | 0.603 | -43.15% | -0.457 | 729.59万 | | SXTC | 苏轩堂 | 1.250 | -37.50% | -0.750 | 4.16亿 | | RGC | 脑再生科技 | 41.420 | -21.67% | -11.460 | 1.66亿 | | IZM | 拍明芯城 | 2.100 | -17.65% | -0.450 | 56.11万 | | YIBO | 星图国际 | 0.8100 | -15.63% | -0.1500 | 4.59万 | ...

Core Insights - flyExclusive, Inc. has seen a stock price increase to $6.94, representing a 121.02% rise, driven by its expansion in private jet operations and strategic positioning for long-term growth [1][5] - China SXT Pharmaceuticals, Inc. has climbed to $4.87, a 143.75% increase, with its focus on traditional Chinese medicine and the Strategic AI Insights Initiative as key growth drivers [2][5] - Pineapple Financial Inc. has experienced a stock price rise to $2.73, a 91.26% increase, attributed to its innovative MyPineapple technology platform and the appointment of Anthony Georgiades to its Board of Directors [3][5] Company Developments - flyExclusive is enhancing its operations in Raleigh, North Carolina, to attract top talent and improve collaboration [1] - China SXT Pharmaceuticals is integrating advanced technology into its operations through AI-supported clinic deployment [2] - Pineapple Financial's strategic positioning is strengthened by the expertise of its new board member in digital assets and institutional investment [3] Market Trends - The movements of these companies indicate strong investor interest in innovation within their sectors, highlighting opportunities for growth in diverse market segments [4]

TAIZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS"), today announced the launch of a Strategic Artificial Intelligence (AI) Insights ...

| 代码 | 名称 | 最新价 | 涨跌幅 √ | 涨跌额 | 成交额 | | --- | --- | --- | --- | --- | --- | | RGC | 脑再生科技 | 52.880 | 60.10% | +19.850 | 1.46亿 | | MTEN | 铭腾国际 | 1.0600 | 21.84% | +0.1900 | 97.34万 | | STFS | 星际时尚 | 0.1230 | 21.42% | +0.0217 | 50.25万 | | SXTC | 苏轩堂 | 2.000 | 18.34% | +0.310 | 21.42万 | | ILLR | Triller Group | 0.0300 | 17.65% | +0.0045 | 1.42万 | 中概股收盘涨幅居前的个股为：脑再生科技涨60.10%，铭腾国际涨21.84%，星际时尚涨21.42%，苏轩 堂涨18.34%，Triller Group涨17.65%。(格隆汇) ...

据交易所数据显示，12月16日，苏轩堂(SXTC)盘中上涨9.93%，截至03:33，报1.55美元/股，成交131.76 万美元，总市值1.80亿美元。 财务数据显示，截至2025年03月31日，苏轩堂收入总额174.09万美元，同比减少9.73%；归母净利 润-330.37万美元，同比减少6.62%。 资料显示，中国苏轩堂药业股份有限公司(简称"中国苏轩堂") 一家创新型的中药制药公司,专注于中药 饮片产品尤其是现代中药饮片(直接口服及泡服饮片)的研发、生产和销售。中药饮片是一种经加工可以 服用的传统中药。几千年以来,中药饮片被中国人广泛使用。 本文源自：市场资讯 作者：行情君 ...

财务数据显示，截至2025年03月31日，苏轩堂收入总额174.09万美元，同比减少9.73%；归母净利 润-330.37万美元，同比减少6.62%。 作者：行情君 据交易所数据显示，12月15日，苏轩堂(SXTC)开盘上涨3.68%，截至22:30，报1.41美元/股，成交2.5万 美元，总市值1.64亿美元。 本文源自：市场资讯 资料显示，中国苏轩堂药业股份有限公司(简称"中国苏轩堂") 一家创新型的中药制药公司,专注于中药 饮片产品尤其是现代中药饮片(直接口服及泡服饮片)的研发、生产和销售。中药饮片是一种经加工可以 服用的传统中药。几千年以来,中药饮片被中国人广泛使用。 ...